Similar articles

• Bimatoprost Imprinted Silicone Contact Lens to Treat Glaucoma.

  Yan F, Liu Y, Han S, Zhao Q, Liu N. Yan F, et al. AAPS PharmSciTech. 2020 Jan 13;21(2):63. doi: 10.1208/s12249-020-1622-6. AAPS PharmSciTech. 2020. Retraction in: AAPS PharmSciTech. 2022 Aug 18;23(7):231. doi: 10.1208/s12249-022-02353-2. PMID: 31933030 Retracted.
• Multiple drug delivery from the drug-implants-laden silicone contact lens: Addressing the issue of burst drug release.

  Desai AR, Maulvi FA, Desai DM, Shukla MR, Ranch KM, Vyas BA, Shah SA, Sandeman S, Shah DO. Desai AR, et al. Mater Sci Eng C Mater Biol Appl. 2020 Jul;112:110885. doi: 10.1016/j.msec.2020.110885. Epub 2020 Mar 23. Mater Sci Eng C Mater Biol Appl. 2020. PMID: 32409042
• Controlled bimatoprost release from graphene oxide laden contact lenses: In vitro and in vivo studies.

  Maulvi FA, Soni PD, Patel PJ, Desai AR, Desai DT, Shukla MR, Shah SA, Shah DO, Willcox MDP. Maulvi FA, et al. Colloids Surf B Biointerfaces. 2021 Dec;208:112096. doi: 10.1016/j.colsurfb.2021.112096. Epub 2021 Sep 2. Colloids Surf B Biointerfaces. 2021. PMID: 34530331
• Bimatoprost/timolol: a review of its use in glaucoma and ocular hypertension.

  Curran MP, Orman JS. Curran MP, et al. Drugs Aging. 2009;26(2):169-84. doi: 10.2165/0002512-200926020-00008. Drugs Aging. 2009. PMID: 19220073 Review.
• Topical bimatoprost: a review of its use in open-angle glaucoma and ocular hypertension.

  Easthope SE, Perry CM. Easthope SE, et al. Drugs Aging. 2002;19(3):231-48. doi: 10.2165/00002512-200219030-00008. Drugs Aging. 2002. PMID: 12027782 Review.